X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (344) 344
Publication (85) 85
Book Review (67) 67
Book Chapter (11) 11
Patent (10) 10
Web Resource (7) 7
Conference Proceeding (5) 5
Book / eBook (4) 4
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (222) 222
humans (211) 211
hematology (115) 115
oncology (104) 104
female (86) 86
multiple myeloma (79) 79
male (75) 75
bortezomib (68) 68
middle aged (60) 60
aged (57) 57
abridged index medicus (54) 54
animals (53) 53
multiple-myeloma (51) 51
waldenstrom macroglobulinemia - drug therapy (50) 50
cancer (45) 45
multiple myeloma - drug therapy (44) 44
adult (42) 42
article (41) 41
mice (39) 39
therapy (39) 39
multiple myeloma - pathology (38) 38
treatment outcome (36) 36
waldenstrom macroglobulinemia - pathology (36) 36
aged, 80 and over (35) 35
prognosis (34) 34
cell line, tumor (31) 31
rituximab (30) 30
antineoplastic agents - therapeutic use (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
expression (29) 29
multiple myeloma - genetics (28) 28
bone marrow (27) 27
disease progression (27) 27
waldenstrom macroglobulinemia - genetics (26) 26
consensus panel recommendations (25) 25
mice, scid (25) 25
2nd international workshop (24) 24
apoptosis (23) 23
multiple myeloma - metabolism (23) 23
bone marrow - pathology (22) 22
survival (22) 22
micrornas - genetics (21) 21
boronic acids - administration & dosage (20) 20
gene expression regulation, neoplastic (20) 20
lymphoid neoplasia (20) 20
pyrazines - administration & dosage (20) 20
cells (19) 19
lenalidomide (19) 19
thalidomide - analogs & derivatives (19) 19
in-vitro (18) 18
monoclonal gammopathy (18) 18
multiple myeloma - therapy (18) 18
signal transduction - drug effects (18) 18
thalidomide (18) 18
waldenstrom macroglobulinemia (18) 18
antineoplastic agents - pharmacology (17) 17
chemotherapy (17) 17
dexamethasone (17) 17
care and treatment (16) 16
hemic and lymphatic diseases (16) 16
bone marrow - metabolism (15) 15
chronic lymphocytic-leukemia (15) 15
disease (15) 15
hematology, oncology and palliative medicine (15) 15
in-vivo (15) 15
lymphoma (15) 15
lymphomas (15) 15
medical research (15) 15
recurrence (15) 15
research (15) 15
risk factors (15) 15
survival analysis (15) 15
antibodies, monoclonal - therapeutic use (14) 14
disease-free survival (14) 14
gene expression (14) 14
mutation (14) 14
patients (14) 14
waldenstrom macroglobulinemia - metabolism (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
cell adhesion - drug effects (13) 13
combination (13) 13
immunoglobulin m - blood (13) 13
international workshop (13) 13
leukemia (13) 13
phase-ii trial (13) 13
review (13) 13
tumors (13) 13
activation (12) 12
boronic acids - therapeutic use (12) 12
cell proliferation (12) 12
cell proliferation - drug effects (12) 12
clinical trials (12) 12
development and progression (12) 12
microbiology (12) 12
multiple myeloma - diagnosis (12) 12
multiple myeloma - mortality (12) 12
pathway (12) 12
progression (12) 12
pyrazines - therapeutic use (12) 12
stem-cell transplantation (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Translational medicine series, ISBN 9781420045109, Volume 4
eBook
Journal of Clinical Investigation, ISSN 0021-9738, 11/2018, Volume 129, Issue 1, pp. 48 - 50
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2019, Volume 129, Issue 1, pp. 48 - 50
Journal Article
Blood, ISSN 0006-4971, 06/2019, Volume 133, Issue 23, pp. 2484 - 2494
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1%... 
Journal Article
2016, Cancer Treatment and Research, ISBN 9783319403182, Volume 169
Web Resource
2016, Cancer Treatment and Research, ISBN 9783319403182, Volume 169
This book provides a concise overview of the state of the art in the biology and treatment of plasma cell malignancies, a heterogeneous group of diseases... 
Medicine | Hematology | Oncology | Molecular biology
Web Resource
2007, Apoptosis : fundamentals, pathways, clinical applications and role in disease
Web Resource
2007, Apoptosis : fundamentals, pathways, clinical applications and role in disease
Web Resource
10/2016, Cancer Treatment and Research, ISBN 9783319403182, Volume 169, 358
This book provides a concise overview of the state of the art in the biology and treatment of plasma cell malignancies, a heterogeneous group of diseases... 
Medicine | Oncology | Molecular Medicine | Medicine & Public Health | Hematology | Plasma cell diseases
eBook
Clinical Cancer Research, ISSN 1078-0432, 12/2014, Volume 20, Issue 23, pp. 5863 - 5865
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 12/2014, Volume 20, Issue 23, pp. 5863 - 5865
Inhibitors of phosphoinositide-3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) and histone deacetylases (HDACs) are effective in non-Hodgkin’s lymphoma... 
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2013, Volume 123, Issue 4, pp. 1542 - 1555
Journal Article
Cell, ISSN 0092-8674, 2011, Volume 146, Issue 6, pp. 904 - 917
Journal Article
2008, Translational medicine series, ISBN 9781420045109, Volume 4
Web Resource
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2014, Volume 111, Issue 28, pp. 10287 - 10292
Bone is a favorable microenvironment for tumor growth and a frequent destination for metastatic cancer cells. Targeting cancers within the bone marrow remains... 
Nanoparticles | Femur | Emulsions | Antineoplastics | Multiple myeloma | Fluorescence | Bones | Pretreatment | Polymers | Cancer | Alendronate-PLGA-PEG | Targeting nanomedicine | Bisphosphonate | Bone metastasis | MULTIPLE-MYELOMA | CELLS | DEXAMETHASONE | ACTIVATION | bone metastasis | VIVO | MULTIDISCIPLINARY SCIENCES | BORTEZOMIB | ANTITUMOR-ACTIVITY | targeting nanomedicine | IN-VITRO | THERAPY | PATHWAY | alendronate-PLGA-PEG | bisphosphonate | Neoplasm Transplantation | Polyglycolic Acid - chemical synthesis | Nanoparticles - chemistry | Humans | Polyglycolic Acid - pharmacology | Polyethylene Glycols - chemistry | Boronic Acids - chemistry | Bone Neoplasms - pathology | Alendronate - chemistry | Bone Neoplasms - metabolism | Drug Delivery Systems | Neoplasms, Experimental - pathology | Multiple Myeloma - drug therapy | Heterografts | Antineoplastic Agents - pharmacology | Bone Neoplasms - drug therapy | Lactic Acid - pharmacology | Tumor Microenvironment - drug effects | Bortezomib | Lactic Acid - chemistry | Nanoparticles - ultrastructure | Polyethylene Glycols - pharmacokinetics | Antineoplastic Agents - chemistry | Multiple Myeloma - metabolism | Xenograft Model Antitumor Assays | Pyrazines - chemistry | Multiple Myeloma - pathology | Animals | Mice, Nude | Polyglycolic Acid - chemistry | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Polyethylene Glycols - chemical synthesis | Lactic Acid - chemical synthesis | Neoplasms, Experimental - metabolism | Pyrazines - pharmacology | Neoplasms, Experimental - drug therapy | Boronic Acids - pharmacology | Bone marrow | Metastasis | Polyethylene glycol | Rodents | Tumors | Index Medicus | Biological Sciences | Physical Sciences
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2015, Volume 90, Issue 6, pp. E122 - E123
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.